A Randomized Study of the Beneficial Effects of Aldosterone Antagonism on LV Function, Structure, and Fibrosis Markers in Metabolic Syndrome | Zendy

Wojciech Kosmala | Zendy; Monika PrzewłockaKosmala | Zendy; Hanna Szczepanik-Osadnik | Zendy; Andrzej Mysiak | Zendy; Trisha O'MooreSullivan | Zendy; Thomas H. Marwick | Zendy

Open Access

A Randomized Study of the Beneficial Effects of Aldosterone Antagonism on LV Function, Structure, and Fibrosis Markers in Metabolic Syndrome

Author(s) -

Wojciech Kosmala,

Monika PrzewłockaKosmala,

Hanna Szczepanik-Osadnik,

Andrzej Mysiak,

Trisha O'MooreSullivan,

Thomas H. Marwick

Publication year - 2011

Publication title -

jacc. cardiovascular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.79

H-Index - 120

eISSN - 1936-878X

pISSN - 1876-7591

DOI - 10.1016/j.jcmg.2011.08.014

Subject(s) - spironolactone , medicine , cardiology , fibrosis , myocardial fibrosis , endocrinology , cardiac fibrosis , diastole , aldosterone , procollagen peptidase , natriuretic peptide , blood pressure , heart failure

The purpose of this study was to identify the effects of spironolactone on left ventricular (LV) structure and function, and serological fibrosis markers in patients with metabolic syndrome (MS) taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research